According to NaturalNews.com, a blood “sleep signature” was linked to up to 71% lower risk of some digestive cancers and was reported at Digestive Disease Week 2026. Participants in the highest third of the sleep proteomic score had a 71% lower liver cancer risk compared with those in the lowest third. The study was observational and does not establish that better sleep causes lower cancer risk.
Researchers led by Yangyang Liu of Memorial Sloan Kettering Cancer Center analyzed UK Biobank records from 472,105 participants. Their work included a five-trait sleep score and an analysis of 303 plasma proteins in 52,920 participants.
What Did the Sleep Study Find?
The broader five-trait analysis assessed sleep duration, chronotype, insomnia, snoring and daytime sleepiness. Compared with poor sleepers, participants with healthy sleep patterns had a 36% lower liver cancer risk and a 14% lower lung cancer risk, according to the research team led by Yangyang Liu.
The protein analysis produced separate cancer-risk associations. Among participants in the highest third of the sleep proteomic score, researchers reported the following comparisons with the lowest third:
- 71% lower liver cancer risk
- 54% lower stomach cancer risk
- 54% lower gallbladder cancer risk
- 53% lower pancreatic cancer risk
- 35% lower esophageal cancer risk
- 28% lower colorectal cancer risk
Yangyang Liu and the research team said the proteomic biomarkers may help clarify biological pathways connecting sleep health with cancer risk. Conference organizers said the blood-based signature could be more sensitive than people’s reports of how they sleep.
How the Three Analyses Differ
| Analysis | Population | Exposure | Outcome | Follow-up | Limitation |
|---|---|---|---|---|---|
| Five-trait sleep score | 472,105 UK Biobank participants | Duration, chronotype, insomnia, snoring and daytime sleepiness | Healthy sleep patterns were associated with lower liver and lung cancer risks | Not stated | Observational association |
| 303-protein sleep signature | 52,920 UK Biobank participants with blood samples | Plasma-protein score divided into thirds | Higher scores were associated with lower risks of six digestive cancers | Not stated | Observational association |
| Sleep-duration mortality study | UK Biobank participants | Sleep of six hours or less and sleep of nine hours or more | Both were associated with increased risk of death from digestive-system cancer | Not stated | Observational association |
What Does the Sleep Score Measure?
The five-trait score considers more than time in bed. Duration reflects whether a participant gets enough sleep, chronotype reflects the fit between the sleep schedule and the body clock, and the other traits cover insomnia, snoring and daytime sleepiness. People with the same sleep duration can differ across these other measures.
Poor Sleep Patterns and Gastrointestinal Cancer Mortality in 2025
A 2025 prospective cohort study defined poor sleep as sleeping less than seven hours per day or more than nine hours, together with late chronotype, frequent insomnia, snoring and frequent daytime dozing. The study associated this pattern with higher mortality from overall gastrointestinal cancer, esophageal cancer and liver cancer.
The reported hazard ratios were 1.32 for overall gastrointestinal cancer, 1.37 for esophageal cancer and 2.01 for liver cancer. Participants who had both a poor sleep pattern and high genetic risk had the highest mortality risks for esophageal, stomach, colorectal and liver cancers. The findings show an association between the combined pattern and mortality, not the effect of changing any one sleep trait.
What Other Sleep Research Adds
A 2026 European Journal of Cancer Prevention study examined sleep duration, selected circulating biomarkers and colorectal cancer risk. Its topic is related to the conference research because it also considers circulating markers alongside sleep, although it is a separate study and does not establish the 303-protein sleep signature described at Digestive Disease Week.
Its poor-sleep definition combined short or long duration with late chronotype, frequent insomnia, snoring and frequent daytime dozing, which provides useful context for viewing sleep as a set of related traits rather than a single duration measure.
The study reported that existing serum tumor markers such as CEA, CA 19-9 and CA 72-4 may not be useful for detecting gastric cancer due to their low sensitivity and specificity, and that endoscopy is currently recommended as the standard for screening and diagnosing gastric cancer, with screening decisions following clinician guidance.
How Common Are Sleep Problems?
The National Heart, Lung, and Blood Institute reports that about 50 million to 70 million Americans have sleep disorders. The research report also states that roughly one in three adults do not get the sleep they need.
Separate research presented at the American Society of Clinical Oncology’s annual meeting involved more than 18 million American adults aged 18 to 50. It linked poor sleep with higher rates of early-onset colorectal, breast, uterine and ovarian cancers.
What to Do Now
- Keep a consistent bedtime.
- Put the phone away before going to bed.
- Get sunlight shortly after waking.
- Avoid a nightcap.
- Ask a doctor about persistent insomnia, loud snoring, daytime sleepiness or a concerning sleep pattern.
Study and Review Sources
- Digestive Disease Week 2026 abstract: Research led by Yangyang Liu of Memorial Sloan Kettering Cancer Center. The material identifies it as a conference abstract, which has not been published as a journal article in the available report.
- BMC Medicine, 2025: Prospective analysis of 406,584 UK Biobank participants examining sleep duration and death from digestive-system cancer. The available material does not provide the paper’s PubMed identifier or publisher link.
- International Journal of Cancer: Mendelian randomization study using 317 chronotype-associated genetic variants from a meta-analysis of 449,734 people. It evaluated morning-chronotype genetic liability against esophageal, stomach, liver, biliary tract, pancreatic and colorectal cancers, using UK Biobank and FinnGen data with 11,952 and 7,638 cases, respectively. The available material does not provide the paper’s PubMed identifier or publisher link.
- Sleep Medicine, 2025: Prospective cohort study of sleep patterns, genetic susceptibility and gastrointestinal cancer mortality, available through the publisher record.
FAQ
What Is a Blood Sleep Signature?
In the conference study, the blood sleep signature was a pattern derived from 303 measured plasma proteins. Participants in the highest third of the resulting sleep proteomic score had lower risks of several digestive cancers than those in the lowest third.
Did the Study Show That Better Sleep Prevents Digestive Cancer?
No. The findings were observational and do not show that improving sleep prevents digestive cancer. The researchers said the biomarkers may help clarify biological pathways connecting sleep health with cancer risk.
What Five Sleep Traits Did the Study Assess?
The study assessed sleep duration, chronotype, insomnia, snoring and daytime sleepiness. Its broader sleep score considered these five traits together rather than examining hours of sleep alone.
Related Coverage
- Low Vitamin D Linked to Mood, PMOS Symptoms, and Sleep Apnea in Women (October 22, 2026): A report published Aug., RDN.
- Studies Associate Antioxidant-Rich Diets With Lower Lung Cancer Risk
- Very Low-Carb Diets Linked to Better Blood Sugar in Children With Type 1 Diabetes
